Structure Therapeutics (ADR)
Develops oral small-molecule medicines for metabolic, cardiovascular, and pulmonary conditions.
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Shares outstanding 57.57M · Float 54.73M · 95.1% free float
Insiders — filings are in the shares behind the receipt.
This listing is a depositary receipt and the Form 4 positions here are filed in the shares behind it, a different unit from the share count and in a ratio the filings never state, so no insider percentage is shown.
Institutions13F, as of Mar 31, 2026
209 holders · 66.72M shares · 39 new positions · 109 increased · 63 reduced · 39 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 8.40M | 14.60% | −308.8K | May 15, 2026 |
| Wellington Management Group LLP | 7.26M | 12.61% | +138.3K | May 15, 2026 |
| Avoro Capital Advisors LLC | 6.56M | 11.39% | 0 | May 15, 2026 |
| Janus Henderson Group PLC | 5.35M | 9.30% | +264.8K | May 18, 2026 |
| Deep Track Capital, LP | 4.28M | 7.43% | +168.1K | May 15, 2026 |
| BVF Inc/IL | 3.46M | 6.01% | −19.7K | May 15, 2026 |
| Morgan Stanley | 2.31M | 4.00% | +217.6K | May 15, 2026 |
| Price T Rowe Associates Inc /MD/ | 2.00M | 3.48% | +329.6K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 15.00% | 31.11M | 13G | Feb 5, 2026 ↗ |
| Wellington Management Group LLP | 10.10% | 21.37M | 13G | Feb 10, 2026 ↗ |
| Avoro Capital Advisors LLC | 9.38% | 16.22M | 13G | Nov 14, 2025 ↗ |
| Janus Henderson Group PLC | 7.70% | 4.45M | 13G | Nov 14, 2025 ↗ |
| Ein # | 6.90% | 3.96M | Nov 14, 2024 ↗ | |
| Deep Track Capital, LP | 5.95% | 12.34M | 13G | Feb 13, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | Filed |
|---|---|---|---|
| Raymond C. Stevens | director, officer: CHIEF EXECUTIVE OFFICER | 5.8K | Mar 5, 2026 |
| Jun Yoon | officer: CHIEF FINANCIAL OFFICER | 2.9K | Jul 3, 2025 |
| FMR LLC | 10 percent owner, other: See Remark 1 | 1.4K | Jul 24, 2026 |
| Crespo Blas Coll | officer: CHIEF MEDICAL OFFICER | 1.2K | Jul 3, 2025 |
| Ashley Hall | officer: Chief Development Officer | 462 | Mar 5, 2026 |
1 ten-percent owner holds 1.4K shares by Form 4 — the 13D/G table above shows that stake, the figure above counts officers and directors only · 3 people have not refiled in the last 18 months (277.5K shares), so they are not in the figure above · 13 positions are filed in the unlisted share unit (9.50M shares), which no share count here divides
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 18, 2026 | Xichen Linofficer: CHIEF SCIENTIFIC OFFICER | Sale · 3 lots | 3,939 | 0 | |
| Aug 4, 2026 | Xichen Linofficer: CHIEF SCIENTIFIC OFFICER | Sale · 2 lots | 3,939 | 0 | |
| Jul 22, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sale · 2 lots | 17,452 | 1,369 | |
| Jul 14, 2026 | Xichen Linofficer: CHIEF SCIENTIFIC OFFICER | Sale · 2 lots | 7,878 | 0 | |
| Jun 25, 2026 | Xichen Linofficer: CHIEF SCIENTIFIC OFFICER | Sale | 7,878 | 0 | |
| Apr 14, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sale · 2 lots | 17,452 | 2,736 | |
| Jan 15, 2026 | FMR LLC10 percent owner, other: See Remark 1 | Sale · 8 lots | 17,452 | 4,103 | |
| Dec 8, 2025 | FMR LLC10 percent owner, other: See Remark 1 | Sale · 10 lots | 52,356 | 0 |
CongressHouse and Senate disclosures
Not reported.